SRPT Competitors & Alternatives
Compare Sarepta Therapeutics Inc with similar stocks in the same industry
Biotechnology
SRPT
Main Stock$17.34
Tradestie Score
53
Market Cap
$2.02B
P/E Ratio
50.4
Revenue Growth
0.0%
Analyst Upside
+26.9%
Top Competitors
219 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
NTLA
Intellia Therapeutics, Inc
|
$15.79
|
$2.01B | - | 56 | Compare |
|
COGT
Cogent Biosciences, Inc. Common Stock
|
$36.01
|
$1.97B | - | 63 | Compare |
|
OCUL
Ocular Therapeutix, Inc.
|
$10.14
|
$1.92B | - | 62 | Compare |
|
CELC
Celcuity Inc. Common Stock
|
$90.31
|
$1.92B | - | 52 | Compare |
|
LQDA
Liquidia Corporation Common Stock
|
$76.43
|
$1.90B | 418.1 | 66 | Compare |
|
VERA
Vera Therapeutics, Inc. Class A Common Stock
|
$37.92
|
$1.84B | - | 57 | Compare |
|
IMCR
Immunocore Holdings plc American Depositary Shares
|
$29.81
|
$1.81B | - | 59 | Compare |
|
ABCL
AbCellera Biologics Inc. Common Shares
|
$5.83
|
$1.78B | - | 56 | Compare |
|
DYN
Dyne Therapeutics, Inc. Common Stock
|
$21.22
|
$1.78B | - | 60 | Compare |
|
VRDN
Viridian Therapeutics, Inc. Common Stock
|
$17.30
|
$1.74B | - | 65 | Compare |
More SRPT Analysis
Data updated: Jun 23, 2026 | Industry: Biotechnology (SIC 2834)
219 stocks in this industry